FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37081911000001109: Cuprior 150mg tablets (Orphalan UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1124471000001112 Cuprior 150mg tablets (Orphalan UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1124481000001114 Cuprior 150mg tablets (Orphalan UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cuprior 150mg tablets (Orphalan UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Trientine true Inferred relationship Existential restriction modifier
Cuprior 150mg tablets (Orphalan UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cuprior 150mg tablets (Orphalan UK Ltd) Is a Trientine 150mg tablets true Inferred relationship Existential restriction modifier
Cuprior 150mg tablets (Orphalan UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cuprior 150mg tablets (Orphalan UK Ltd) Is a Cuprior true Inferred relationship Existential restriction modifier
Cuprior 150mg tablets (Orphalan UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cuprior 150mg tablets (Orphalan UK Ltd) Has specific active ingredient Trientine tetrahydrochloride false Inferred relationship Existential restriction modifier
Cuprior 150mg tablets (Orphalan UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cuprior 150mg tablets (Orphalan UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cuprior 150mg tablets (Orphalan UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cuprior 150mg tablets (Orphalan UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cuprior 150mg tablets (Orphalan UK Ltd) Has specific active ingredient Trientine tetrahydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cuprior 150mg tablets (Orphalan UK Ltd) 72 tablet 9 x 8 tablets Has AMP True Cuprior 150mg tablets (Orphalan UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start